CD&R, TPG Look to Blue Owl to Finance $2.5 Billion Covetrus Debt

Clayton Dubilier & Rice and TPG Inc. are in talks with private credit firms including Blue Owl Capital Inc. to line up at ...
Nasdaq

CD&R’s Influence Over Resideo Technologies: Balancing Power and Potential Conflicts

Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding approximately 11% of Resideo Technologies’ total voting power as ...
U.S. News & World Report

CD&R Nears Deal to Buy Sanofi's Consumer Unit for $16 Billion, Source Says

(Reuters) -Sanofi is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier & Rice (CD&R), a person familiar with ...
PE Hub

CD&R in talks to buy 50% stake in Sanofi’s consumer healthcare unit Opella

Opella achieved 6.3 percent sales growth at constant exchange rates in 2023 Sanofi is a global healthcare company based in Paris CD&R is a global private investment firm Clayton Dubilier & Rice (CD&R) ...